鸡白细胞介素2在毕赤酵母中的表达与生物活性分析
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
家禽传染性疾病是养禽业中最大的威胁,给养殖业造成严重经济损失,免疫预防则是控制疾病的重要战略。但是在实际生产中,并不是所有疾病均有疫苗可用,也不是所有疫苗均可对机体产生完全免疫保护。特别是一些灭活苗和基因工程苗由于抗原性低等原因,免疫效果往往并不理想,时常造成免疫失败。
     鸡白细胞介素-2(Chicken Interleukin-2, ChIL-2)在家禽养殖业中可作为免疫佐剂,提高鸡体抵抗病原的免疫力,自1982年被发现以来一直是细胞因子研究中的热点之一,可望与疫苗配合使用,成为一种重要的细胞免疫佐剂,提高机体抗感染力,增强灭活苗或基因工程疫苗免疫效果。
     本文利用毕赤酵母(Pichia Pastoris)表达重组ChIL-2并对其提高鸡免疫功能的生理活性作了研究。首先将ChIL-2克隆至毕赤酵母穿梭表达质粒pPIC9K构建重组质粒pPIC9K/ChIL-2,经Sal I线性化酶切,电穿孔将其整合到毕赤酵母GS115(His+Mut+)染色体上,利用MM、MD平板筛选His+Mut+型阳性克隆,再用高浓度G418-YPD平板筛选高拷贝转化子。共筛选到了5株阳性克隆,用菌落PCR做进一步的筛选,得到3株高拷贝菌株。筛选到的高拷贝菌株进行BMGY/BMMY摇瓶培养,诱导表达重组ChIL-2。经SDS-PAGE与Western blot分析,证实ChIL-2基因在重组GS115中成功表达出约16 kDa与14 kDa两条特异性条带,这与天然ChIL-2分子量大小一致,提示与天然蛋白一样,重组ChIL-2可能也为糖基化蛋白。
     将重组的酵母菌株进行发酵生产,其表达量较摇瓶培养提高了20倍左右,达到约100 mg/L,重组目标蛋白质量分数达总蛋白的50 %以上。由于目的蛋白与杂蛋白带大小相差甚大,通过膜过滤截留就得到了高纯度的目的蛋白,操作简单。本研究为工业化生产鸡白细胞介素-2奠定了基础。
     将纯化到的ChIL-2与疫苗一起联合免疫鸡群,研究其作为免疫增强剂对禽流感病毒(avian influenza virus, AIV)疫苗和新城疫病毒(Newcastle disease virus, NDV)疫苗的免疫增强效果,用血凝抑制试验检测鸡体血清中的AI抗体和ND抗体水平。实验结果表明:ChIL-2与禽流感或新城疫疫苗同时使用对疫苗有良好的免疫增强作用,能有效提高鸡体抗体滴度,延长抗体滴度的时间,提高存活率。ChIL-2的使用剂量应该在8.35μg/鸡左右。在使用的过程中,ChIL-2没有发现任何毒副作用,证明是一种安全高效的免疫增强剂。
Domestic infective diseases wich caused the tremendous economic losses to poultry industry, were the most large threat of poultry industry. The application of vaccines was the most improtant strategy to guard against these diseases. In the poultry industry, there are various vaccines to different diseases, but they are not effective to all diseases. In addition, vaccines could not entirely protect fowls from given disease. In particular, the low antigenicity of inactivated vaccines and genetically engineered vaccines often cause failure during immunization.
     Chicken interleukin-2 (ChIL-2) can be used as immunological adjuvant in the poultry industry to enhance the immunity of chickens against pathogens. It had been a focus in the cytokines’study since it was found in 1982. It was used as an important adjuvant in cell immunity.
     In the present study, the chicken interleukin-2 gene was inserted into the expression vector pPIC9K to construct recombinant plasmid (pPIC9K/ChIL-2) followed by linearizing by restriction endonuclease Sal I. Then it was transformed into host Pichia Pastoris GS115 by eletroporation. After screening by G418-YPD, following by MM and MD plates, we obtained 5 positve clonies (His+Mut+). In the next PCR, 3 clonies with high-copy of purpose gene were obtained. Among them, one colony was cultured in BMGY/BMMY flask for the expression of ChIL-2 in vitro. The expression of recombinant ChIL-2 was successfully performed. Similarly to native ChIL-2, the expressed ChIL-2 revealed two main bands corresponding to molecular masses of 16 and 14 kDa, respectively as detected by SDS-PAGE and Western blot, suggesting it could be a glycosylated protein.
     By fermentation, the production of recombinant protein increased about 20-fold, up to 100 mg/L. In the total cell proteins, the target protein ChIL-2 occupied more than 50 %. Because the great difference of molecular masses between the proteins in the cell culture, membrane ultrafiltration purification was applied to ChIL-2 purification and was a convenient way. The present study established a foundation for the industrial production of ChIL-2.
     Purified ChIL-2 was co-admitted with avian influenza virus (AI) vaccine and newcastle disease (ND) vaccine to study its immunological enhancing effect on AI and ND in chickens.The antibody titers of AI and ND were detected by hemagglutination inhibition test. The results indicated that ChIL-2 had positive immuno-enhancing effect on both vaccines. The immuno-enhancing effects were respresented by antibody titer increasing and its extending. ChIL-2 also increased the survival rate of the chickens. The optimum dosage of ChIL-2 as adjuvant was about 8.35μg/chicken.During the whole experiment periods,no toxic effect of ChIL-2 was identified, suggesting it was an effective and safe adjuvant for vaccination.
引文
[1] Morgen D A. Selective in vitro growth of T lymphocytes from normal human bone marrows[J]. Science, 1976, 193: 1007-1008
    [2] Peet N M, Mckeating J A, Souza J B. The effect of low-profile serine substitutions in the v3 loop of HIV-1 gp120 IIIB/LAT on the immunogenicity of the envelope protein [J]. Virology, 1998, 251(1): 59-70
    [3] Taniguchi T, Matsui H, Fujita T,et al. Structure and expression of a cloned cDNA for human interleukin-2[J]. Nature, l983, 302: 305-310
    [4] Yokota T, Arai N, Lee F, et a1. Use of a cDNA expression vector for isolation of mouse interleukin-2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells[J]. Proc Natl Acad Sci USA, 1985, 82: 68-72
    [5] Vandergrifft E V, Horohov D W. Molecular cloning and expression of equine interleukin-2[J]. Vet Immunol Immunopathol, l993, 39: 395-406
    [6] Mai Z, Kousoulas K G, Horohov D W, et a1. Cross-species PCR cloning of gerbil (Meriones unguiculatus) interleukin-2 cDNA and its expression in COS-7 cells[J]. Vet Immunol Immunopatho1, 1994, 40(1): 63-71
    [7]孙为民,王惠琴.细胞因子研究方法学[M].北京:人民卫生出版社,1999:20-86.
    [8]独军政,刘胜旺,陈怀涛,等.鸡白细胞介素15的研究进展[J].动物医学进展,2004,25(04):59-62.
    [9]邵卫星,彭大新,卢建红,等.鸡的7种细胞因子的一些分子生物学特性[J].动物医学进展,2004,5(4):11-15.
    [10] Schauenstein K, Globerson A, Wick G. Avain lymphokines: thymic cell growth factor in supernatants of mitogen stimulated chicken spleen cells[J]. Dev Comp Immunol, 1982, 6: 533-540.
    [11] Lillehoj H S, Kaspers B, Jenkins M C, et al. Avian interferon and interleukin-2. A review by comparison with mammalian homologues[J]. Poultry Sci Rev, 1992, 4: 67-85.
    [12] Schnetlzler M, Oommen A, Nowak J S, et al. Characterization of chicken T Cell growth factor[J]. Eur J Immunol, 1983, 13: 560-566
    [13] Vainio O, RatcliffeM J H, Leanderson T, et al. Chicken T cell growth factor use in the generation of a long term cultred T cell line and biochemical characterization[J]. Scand J Immunol, 1986, 23(1): 135-142.
    [14] Frederickson T L, Sharma. Purification of avian T cell growth and immune interferon using gelfiltrition high resolution chromatographe[J]. Avain Immunol, 1987, 238, 145-156.
    [15] Myers T J, Lillehoj L H, Fetterer R H. Partial purification and charaterization of chicken interleukin-2[J]. Vet Immunol Immunopathol, 1992, 34: 97-114
    [16] Thiagarajan D, Ram G C, Bansal M P. Optimum conditions for in vitro chicken IL-2 production and its in vivo role in new castle disease vaccinated chickens[J]. Vet Immunol Immunopathol, 1999, 67: 79-61.
    [17] Cao M J, Kwang J. Monoclonal antibody production and purification of native chicken interleukin-2 [J]. Pharm Biotechnol, 2004, 11(4): 232-237.
    [18] Sundick R S, Gill-Dixon C. A cloned chicken lymphokine homologous to both mammaliam IL-2 and IL-15[J]. J. Immunol, 1997, 159(2): 720-725
    [19] Kaiser P, Mariani P. Promoter sequence, exon: intro structure, and synteny of genetic location show that a chicken cytokine with T-cell proliferation activity is IL-2 not IL-15[J]. Immunogenetics, 1999, 49: 26-35.
    [20] Lillehoj H S, Min W, Choi K D, et al. Molecular, cellular and functional characterization of chicken cytokines homologous to mammalian IL-15 and IL-2[J]. Vet Immunol Immunopathol, 2001, 82: 229-244
    [21]李宏梅.重组鸡白细胞介素-2作为免疫增强剂的研究[D].南京:南京农业大学, 2000
    [22]李祥瑞.鸡IL-2 cDNA克隆[J].南京农业大学学报, 1999, 22(2): 80-84
    [23]陈洪岩,刘胜旺,陈奖励,等.鸡IL-2基因的克隆及序列测定[J].中国兽医科技,1999, 29(7): 5-7
    [24]李建荣,黄耀伟,孟松树,等.我国地方品种萧山鸡白介素2(IL-2)基因的克隆及分子进化分析[J].生物化学与生物物理学报,2001, 33 (6): 713-718
    [25] Waldmann T A, Dubois S, Tagaya Y, et al. Contrasting roles of interleukin-2 and interleukin-15 in the life and death of lymphocytes: implications for immunotherapy [J]. Immunity, 2001, 14(2): 105-110.
    [26] Kolodsick J E, Stepaniak J A, Hu W, et al. Mutational analysis of chicken interleukin 2[J]. Cytokine, 2001, 13(6): 317-324
    [27] Lowenthal J W,Lambrechet B,vandenBerg T P,et al. Avian cytokines-the natural approach to therapeutics[J]. Dev Comp Immunol, 2000, 24: 355-365.
    [28]郭川,郑忠辉,吴国平,等.鸡白细胞介素2基因的克隆、原核表达及功能研究[J].福州大学学报(自然科学版),2006,34(5): 760-765
    [29]巴德年.当代免疫学技术与应用[M].北京:北京医科大学中国协和医科大学联合出版社,1998:49-71.
    [30] Stacheli P, Puehler F, Schneider K, et al. Cytokines of birds: consered of functions-a largely different look[J]. J Interferon Cytokine Res, 2001, 21: 993-1010.
    [31] Pfol J L, Hester J B, Doelling V W, et al. Development of a highly quantitative、reproducible assay for determination of chieken T cell growth factor biological activity[J]. Poult Sci, 1997, 76(10): 1379-1386.
    [32] StePaniak J A, Shuster J E, Hu W, et al. Production and in vitro characterization of recombinant chicken interleukin-2[J]. Interferon Cytokine Res, 1999, 19(5): 515-526.
    [33] Conel C, Thomas J L. Establishment of an IL-2-dependent,antigen nonspecific chieken T-cell line[J]. Dev Comp Immunol, 1990, 14(4): 439-446.
    [34]邵卫星.分别表达鸡白细胞介素l B、白细胞介素2和骨髓单核细胞生长因子基因重组鸡痘病毒的构建及其对ND疫苗免疫力的影响[D].扬州:扬州大学, 2004.
    [35] Choi K D, Lillehoj H S, Song k D, et al. Molecular and functional characterization of chicken lL-15[J]. Dev Comp Immunol, 1999, 23: 165-177.
    [36]周继勇,陈吉刚,王金勇,等.鸡白细胞介素-2基因在Pichia methanolica酵母中的表达[J].浙江大学学报(农业与生命科学版), 2003, 29(4): 419-423.
    [37]许健,樊拥军,李龙,等.鸡白细胞介素2在毕赤酵母细胞中的表达[J].西安交通大学学报(医学版), 2004, 25(4): 339-342.
    [38] Cao M J, Wu G P, Guo C, et al. Expression of chicken interleukin-2 in insect cells [J]. Biochemistry (Moscow), 2005, 70(11): 1223-1226.
    [39] Lillehoj H S, Kang S Y, Keller L, et al. Eimeria tenella and Eacervulina: lymphokines secreted by an avian T cell lymphoma or by sporozoite-simulated immune T lymphocytes protect chickens against avian coccidiosis[J]. Expparasitol, 1989, 69: 54-64.
    [40] Tellez G I, Kogut M H, Hargis. Immunoprophylaxis of salmonella enteritidis infection by lymphokines in leghorn chickens[J]. Avian Dis, 1993, 37: 1062-1070.
    [41] Chiok D, Lillehoj H S. Role of chieken IL-2 on gammadelta T-cells and Eimeria acervulina-induced changes in intestinal IL-2 mRNA expression and gammadelta T-cells[J]. Vet Immunol Immunopathol, 2000, 73(3): 309-321.
    [42] Liu L, watabes, Yang J, et al. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses[J]. Vaccine, 2001, 20(l): 42-48.
    [43] Chow Y H, Huang W, Chi W, et al. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing Hepatitis B surface antigen and interleukin-2[J]. Virol, 1997, 71: 169-178.
    [44] Chow Y H, Chiang B L, Lee Y L. Development of Thl and Th2 population and the nature of immune response to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine gene[J]. J Immunol, 1998, 160: 1320-1329.
    [45] Geissler M, Gisien A, TokDashige K, et al. Enhancement of cellular and humoral immune responses to Hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids[J]. J Immunol, 1997, 158: 1231-1237.
    [46] Nobiron I, Thompson I, Browline J, et al. Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhea virus[J]. Vet Microbiol, 2000, 76: 129-142.
    [47] Min W, Lillehoj H S, Burnside J, et al. Adjuvant effeets of IL-1β, IL-2,IL-8, IL-15, IFN-α, IFN-γ, TGF-β4 and lymphotactin on DNA vaccination against Eimeria acervulina[J]. Vaccine, 2001, 20(l): 267-274.
    [48]于涟,李建荣,黄耀伟,等.鸡白介素2增强传染性法氏囊病病毒多聚蛋白DNA疫苗免疫原性的研究[J].生物工程学报,2001,17(6):652-657
    [49]费聿锋,钱建飞,凌雯.重组鸡IL-2增强鸡四联灭活苗免疫效果的研究[J].畜牧与兽医,2004: 9-11
    [50]李宏梅,郭慧君,李祥瑞.重组鸡IL-2作为传染性法氏囊病疫苗免疫增强剂对鸡细胞免疫水平的影响[J].中国兽医杂志,2005,41(6):13-14
    [51]谢荣辉,万旺军,李龙,等.鸡白细胞介素2口服免疫佐剂增强传染性法氏囊病病毒DNA疫苗免疫效果的研究[J].浙江大学学报(农业与生命科学版),2007,33(3):237-242
    [52] Ramshaw I A. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection[J]. Nature, 1987, 329: 545-546.
    [53] Flexner C, Hugin A, Moss B. Prevention of vaccinia virus infection immunodeficient mice by vector directed IL-2 expression[J]. Nature, 1987, 330: 259-261.
    [54] Flexner C, Moss B, London W T, et al. Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2[J]. Vaccine, 1990, 8: 17-21.
    [55]姜永厚,陈奖励,宋秀龙,等.鸡新城疫病毒F基因和鸡IL-2重组DNA疫苗的构建[J].中国预防兽医学报,2001,23(2):81-83.
    [56] Buscaglia C,Calnek B W. Maintenance of marek’s disease herpesvirus in vitro by factor found in conditioned medium[J]. Gen Virol, 1988, 69: 2809-2818.
    [57] Quere P,Suppression mediated in vitro by Marker’s disease virus transformed T-lymphoblastoid cell lines: effect on lympho proliferation[J]. Vet Immunol Immunopathol,1992, 32(l): 149-164.
    [58] Xing Z,Sehat K A. Expression of cytokine genes in Marek’s disease virus-infected chickens and chicken embryo fibroblast cultures[J]. Immunology, 2000, 100: 70-76
    [59] Adair B M, Mcneilly F, Mcconnell C D, et al. Effects of chicken anemia agent on lymphokine production and lymphocyte transformation in experimentally infected chickens[J]. Avian Dis, 1991, 35(4): 783-792.
    [60] Mcconell C D, Adair B M, mcnulty M S. Effects of chicken anemia virus on cell-mediated immune function in chickens exposed to the virus by natural route[J]. Avian Dis, 1993, 37(2): 366-374.
    [61] Isobe T, Lillehoj H S. Dexamethasone suppresses T cell-mediated immunity and enhances disease susceptibility to Eimeria mivati infection[J]. Vet Immunol Immuno Pathol, 1993, 39(4): 431-446.
    [62] Breed D G,Scetters T P,Verhoeven N A,et al. Characterization of Phenotype related responsiveness of peripheral blood lymphocytes from Eimeria tenella infected chiekens[J]. Parasite Immunol, 1997, 19(12): 563-569.
    [63]张国平. IL-2能有效降低疫苗免疫对鸡上呼吸道损伤的实验报告[J].中国禽类导刊,2004,21(5):32
    [1] Stepaniak J A, Shuster J E, Hu W, et al. Production and in vitro characterization of recombinant chicken interleukin-2 [J]. J Interferon Cytokine Res, 1999, 19(5): 5l5-526
    [2] Burel C, Cha K, Reeves P J, et al. Rhodopsin kinase: Expression in mammalian cells and a two-step purification[J]. Proc Natl Acad Sci USA. 2000, 97(7): 3004-3009.
    [3] Hitzeman R A, Hagie F E, Levine, et al. Expression of a human gene for interferon in yeast[J]. Nature, 1981, 293: 717-722
    [4] Valenzuela P, Medina A, Rutter W J, et al. Synthesis and assembly of hepatits B virus surface antigen particles in yeast[J]. Nature, 1982, 298: 347-350
    [5] Chen C Y, Opperman H, Hitzeman R A. Homologus versus heterologous gene expression in the yeast[J]. Nucl Acids Res, 1984, 12: 8951-8970
    [6] Innis M A, Holland M J, Maccabe P C, et al. Expression glycosylation and secretion of an Aspergillus glucoamylase by Saccharomyces cerevisiae[J]. Science, 1985, 228: 21-26
    [7] Wen D, Schelesingeer M J. Expression of sindbis and vesicular stomatitis virus glycoproteins in Saccharomyces cerevisiae[J]. Proc Natl Acad Sci USA, 1986, 83: 3639-3643
    [8] Primrosse S B, Derbyshire P, Jones I M, et al. Hereditary instability of recombinant DNA molecules[J]. Soc Gen microbial, 1983, 10: 63-67
    [9] Serienc F,Campbell J L, Bailey J E. Analysis of unstable recombinant Saccharomyces cerevisiae population growth in selective medium[J]. Biotechnol Bioeng, 1986, 28: 70-71
    [10]欧阳立明,张惠展,张嗣良,等.巴斯德毕赤酵母的基因表达系统研究进展[J].生物化学与生物物理学报, 2000, 27(2): 151-154.
    [11]王谨,李天增,才学鹏.甲醇酵母表达外源基因的研究近况[J].中国兽医科技,2003,33(7):34-38
    [12] Wegner M, Eugene H. Biochemical conversions by yeast fermentation at high cell densities[P]. US: 4414329, 1983-11-08.
    [13] Borgheresi R A, Palma M S, Ducancel F, et al. Expression and processing of recombinant sarafotoxins precursor in Pichia pastoris[J]. Toxicon, 2001, 39: 1211-1218
    [14] Cregg J M, Vedvick T S, Raschke W C. Recent advances in the expression of foreign genes in Pichia pastoris [J]. Biotechnology, 1993, 11(8): 905-910.
    [15]章如安,杨晟,邱荣德,等.巴斯德毕赤酵母表达体系研究及进展[J].微生物学通报,2000,27(5): 371-73.
    [16]李晶,赵晓祥,沙长青,等.甲醇酵母基因表达系统的研究进展[J].生物工程进展,1999,19(2):17-20.
    [17]朱剑昆,许志祥,黄伟达,等.人重组白细胞介素11在毕赤酵母系统中的表达及纯化[J].中国医学科学院学报,2001,23(2):127-131
    [18] Monteino R,Garcia R,Quintero O,et al. Variation in N-linked oligo saccharide structures on heterologous proteins secreted by the methylotrophic yeast Pichia pastoris[J]. Protein Expr Purif, 1998, 14(2): 197-207.
    [19] Sundick R S,Gill-Dixon C. A cloned chicken lymphokine homologous to both mammaliam IL-2 and IL-15[J]. J Immunol, 1997, 159(2): 720-725
    [20] Cregg J M, Madden K R, Barringer K J, et al. Functional characterization of the two alcoholoxidase genes from the yeast Pichia pastoris[J]. Mol Cell Biol, 1989, 9: 1316-1323.
    [21] Clare J J, Romanos M A, Rayment F B, et al. Prdouction of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris strains containing multiple gene copies[J]. Gene, 1991, 105: 205-212
    [22] Cregg J M, Cereghino J L, Shi J, et.al. Recombinant proein expression in Pichia Pastoris[J]. Mol Biotechnol, 2000, 16(1): 23-52
    [23]范乔,刘宏迪.甲醇营养型酵母表达外源蛋白的特点及策略[J].微生物学通报,1996,26(4):304-306.
    [24] Cereghino G P, Cereghino J L, Ilgen C, et al. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris[J]. Curr Opin Chem Biol, 2002, 13: 329-332.
    [25]赵翔,霍克克,李育阳.毕赤酵母的密码子用法分析[J].生物工程学报,2000,16(3):308-311
    [26] Hoekema A, Kastelein R A, Vasser M, et al. Codon replacement in the PGK1 gene of Saccharomyces cerevisiae: experimental approach to study the role of biased codon usage in gene expression[J]. Mol Cell Biol, 1987, 7: 2914-2924
    [27] Graham G J, Maio J J. A rapid and reliable method to create tandem arrays of short DNA seguences[J]. BioTechniques, 1992, 13(5): 780-789
    [28]聂东宋,梁宋平,李敏.外源蛋白在巴氏毕赤酵母中高效表达的策略[J].吉首大学学报(自然科学版) , 2001, 22 (3): 40-41
    [29] Thill G P, Dark G R, Stillman G R, et al. Proceedings of the Sixth International Symposium on Genetics of Industrial Micro-organism [J]. Heslot Hed, 1990, 2: 477-490
    [30] Ohashi R,Mochizuki E , Kamoshita Y. High-level expression of the methanol-inducible beta-galactosidase gene by perfusion culture of recombinant Pichia pastoris using a shaken ceramic membrane flask[J] . J Ferment Bioeng, 1998, 86(1): 44-48
    [31] Waterham H R, Digan M E, Koutz P J, et al. Isolation of the Pichia Pastoris glyceroldehyde-3-phosphate dehydrogenase gene and regulation and use of its promoter[J]. Gene, 1997, 186: 37-44.
    [32] Goodric J C, Xu M, Finnegan R, et al. High level expression and stabilization of recombinant human chitinase produces in a continuous constitutive Pichia pastoris expression system[J]. Biotech Bioeng, 2001, 174: 492-497.
    [33]王燕,梁镇和,张友尚,等.人胰岛素在甲醇酵母Pichia pastoris中的分泌表达[J] .生物化学与生物物理学报, 1999: 31(5): 587-589
    [34] Pan X, Cao G W, Ke C W, et al. Structure and function of vascular endotheliol growth factor and its related proteins[J]. Acta Biochim Biophys Sinica, 1999, 31(4): 357-361.
    [1] Cao M J, Kwang J. Monoclonal antibody production and purification of native chicken interleukin-2 [J]. Pharm Biotechnol, 2004, 11 (4): 232-237.
    [2] F. M.奥斯伯,R. E.金斯顿,J. G.塞德曼,等.精编分子生物学实验指南[M].第四版.北京:科学出版社,2005,378-381.
    [3] Marshak D R, Kadonaga J T, Burgess R R, et al.蛋白质纯化与鉴定实验指南[M].北京:科学出版社,2002,256-257.
    [4] Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA, 1979, 76 (9): 4350-4354.
    [5]周继勇,陈吉刚,王金勇,等.鸡白细胞介素-2基因在Pichia methanolica酵母中的表达[J].浙江大学学报(农业与生命科学版), 2003, 29 (4): 419-423.
    [6]许健,樊拥军,李龙,等.鸡白细胞介素2在毕赤酵母细胞中的表达[J].西安交通大学学报(医学版), 2004, 25(4): 339-342.
    [7] Cao M J, Wu G P, Guo C, et al. Expression of chicken interleukin-2 in insect cells [J]. Biochemistry (Moscow), 2005, 70(11): 1223-1226.
    [8] Cao M J, Kwang J. Monoclonal antibody production and purification of native chicken interleukin-2 [J]. Pharm Biotechnol, 2004, 11 (4): 232-237.
    [9]顾园,诸欣平,王少华.毕赤酵母表达蛋白质的糖基化[J].生命的化学,2004,24(4):353-355.
    [10]巍凡华,曹瑞兵,吴润,等.巴斯德毕赤酵母表达系统研究进展[J].农业科学研究. 2007,28(1):68-71
    [11] Wood M J, Komives E A. Production of large quantities of isotopically labeled protein in Pichia pastorisby fermentation [J]. J Biomol NMR, 1999, 13(2): 149-159
    [12] Romanos M. Advances in the use of Pichia pastoris for high level gene expression[J]. Curr Opin Chem Biol, 1995, 6(5): 527-533.
    [13] Thorpe E D, Anjon M C, Daugulis A. Sorbitol as a non repressing carbon source for batch fermentation of recombinant Pichia pastoris[J]. Biotech lett, 1999, 21: 669-672
    [14]邱荣德,朱建蓓,王垒,等.人p53蛋白在巴斯德毕赤酵母中的表达[J].生物工程学报,1999,15(4):477-481
    [15] Ohashi R, Mochizuki E, Suzuki T. A mini-scale mass production and separation systemfor secretory heterologous proteins by perfusion culture of recombinant Pichia pastoris using a shaken ceramic membrane flask[J]. J Biosci Bioeng, 1999, 87 (5): 655-660.
    [16]史琪琪,郝玉有,吴康华,等.诱导相温度对毕赤酵母表达重组人复合α干扰素聚合的影响[J].生物工程学报. 2006,22(2):311-315
    [17]孙圣兰,江青艳.白细胞介素-2的研究进展及其在畜禽业中的应用前景[J].广东饲料,2003,12(2):28-30
    [18]欧阳立明,张惠展,张嗣良,等.巴斯德毕赤酵母的基因表达系统研究进展[J].生物化学与生物物理学报,2000,27(2):151-154.
    [19]张英.重组人Elafin在毕赤酵母中的表达鉴定及大规模发酵和纯化工艺研究[D].吉林:吉林大学. 2003
    [20]李春艳,方富林,何旭敏,等.超滤法提纯头孢菌素C的应用研究[J].福建医科大学学报,2001,35(1):53-56
    [1] Lowenthal J W, Lambrecht B, Vandenberg T P, et al. Avian cytokines-the natural approach to therapeutics[J]. Develop Comp Immunol, 2000, 23: 355-365.
    [2]李梦熊.禽疫病检测血样采集与血清分离方法[J].畜牧兽医杂志, 2005, 24(2): 35.
    [3]何维明,高玉鹏,姜艳芬,等.禽流感流行病学调查及病原分离鉴定初报[J].西北农业大学学报, 2001, 10(3): 16-19.
    [4]王天奇,张玲,董发明.正确认识鸡新城疫的免疫机制[J].畜牧兽医杂志, 2001, 20(1): 19-21
    [5]邱艳红,吴峻华,叶玮,等.禽流感-新城疫重组二联活疫苗(rL-H5株)免疫效果分析[J].福建畜牧兽医,2006,28(5):54-55
    [6]徐前明,李祥瑞.重组ChIL-2对禽流感灭活苗免疫增强作用试验[J].动物医学进展,2006,27(10): 99-101.
    [7]费聿锋,钱建飞,凌雯,等.重组鸡IL-2增强鸡四联灭活苗免疫效果的研究[J].畜牧与兽医,2004,36(4):9-10.
    [8] Stepaniak J A, Shuster J E, Hu W, et al. Production and in vitro characterization of recombinant chicken interleukin-2[J]. Interferon Cytokine Res, 1999, 19(5): 515-526.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700